Canature Health Technology Co., Ltd. (300272.SZ)
CNY 6.74
(-0.3%)
CNY 6.74
(-0.3%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 374.83 Million | 155.43 Million | 186.76 Million | 140.42 Million | 114.39 Million | 96.05 Million |
| Net Income | 153.47 Million | 99.42 Million | 117.1 Million | 50.52 Million | 120.45 Million | 349.29 Million |
| Depreciation & Amortization | 76.91 Million | 75.75 Million | 52.11 Million | 37.31 Million | 29.7 Million | 31.5 Million |
| Deferred income taxes | 804.54 Thousand | 4.48 Million | 2.7 Million | 5.81 Million | 45.32 Million | -4.39 Million |
| Stock-based compensation | - | - | - | -3.6 Million | 9.06 Million | 3.41 Million |
| Change in working capital | 121.03 Million | -47.08 Million | 12.77 Million | -43.33 Million | -10.26 Million | 1.6 Million |
| Other non-cash items | 21.01 Million | 27.33 Million | 4.76 Million | 95.91 Million | -25.49 Million | -286.35 Million |
| Investing Cash Flow | -349.67 Million | -59.81 Million | -513.5 Thousand | 55.64 Million | -153.71 Million | -97.44 Million |
| Investments in PPE | -80.23 Million | -94.58 Million | -71.28 Million | -43.14 Million | -58.86 Million | -41.11 Million |
| Acquisitions | -7.91 Million | 2.64 Million | 99.88 Million | 48.76 Million | -84.67 Million | 94.35 Million |
| Investment purchases | -267.1 Million | -115 Million | -111.03 Million | -447.84 Million | -1.64 Billion | -376.35 Thousand |
| Sales/Maturities of investments | 5 Million | 143.12 Million | 70.16 Million | 541.01 Million | 1.63 Billion | 1 Million |
| Other Investing Activities | -7.9 Million | 4 Million | 11.75 Million | -43.14 Million | 1.2 Million | -151.31 Million |
| Financing Cash Flow | 430.28 Million | 30.98 Million | -96.6 Million | -182.16 Million | 28.42 Million | 52.86 Million |
| Debt repayment | -266.04 Million | -332.9 Million | -418.35 Million | -409.93 Million | -234.79 Million | -142.28 Million |
| Dividends payments | -56.17 Million | -56.71 Million | -28.46 Million | -29.13 Million | -77.49 Million | -51.43 Million |
| Common Stock Repurchased | - | -31.37 Million | -37.99 Million | -35.88 Million | -809.1 Thousand | - |
| Common Stock Issuance | - | 31.37 Million | 37.99 Million | 35.88 Million | 809.09 Thousand | - |
| Other Financing Activities | 253.82 Million | 433.75 Million | 362.61 Million | 269.98 Million | 353.79 Million | 246.57 Million |
| Accounts receivables | -4.74 Million | 26.17 Million | -91.74 Million | -9.26 Million | -47.56 Million | 8 Million |
| Accounts payables | 62.6 Million | -39.89 Million | 153.06 Million | -20.81 Million | 18.09 Million | 24.93 Million |
| Inventory | 62.37 Million | -37.83 Million | -64.99 Million | -19.07 Million | -26.11 Million | -26.94 Million |
| Other working capital | 1.63 Million | 4.48 Million | 16.45 Million | 5.81 Million | 45.32 Million | 28.54 Million |
| Cash at beginning of period | 400 Million | 258.57 Million | 168.08 Million | 146.86 Million | 152.71 Million | 98.23 Million |
| Cash at end of period | 875.9 Million | 400 Million | 258.57 Million | 168.08 Million | 146.86 Million | 152.71 Million |
| Capital Expenditure | -80.23 Million | -94.58 Million | -71.28 Million | -43.14 Million | -58.86 Million | -41.11 Million |
| Effect of forex changes on cash | 20.45 Million | 14.82 Million | 840.24 Thousand | 7.3 Million | 5.04 Million | 3 Million |
| Net cash flow / Change in cash | 475.89 Million | 141.43 Million | 90.49 Million | 21.22 Million | -5.84 Million | 54.47 Million |
| Free Cash Flow | 294.59 Million | 60.85 Million | 115.47 Million | 97.28 Million | 55.53 Million | 54.93 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 27.13 Million | 34.74 Million | 22.29 Million | 3.12 Million | 153.47 Million | 75.53 Million |
| Depreciation & Amortization | - | 19.76 Million | 19.76 Million | 76.91 Million | 76.91 Million | -37.76 Million |
| Deferred income taxes | - | - | - | - | 804.54 Thousand | - |
| Stock-based compensation | - | 10.16 Million | - | - | - | - |
| Change in working capital | - | -34.79 Million | - | 59.27 Million | 121.03 Million | -58.57 Million |
| Other non-cash items | 65.72 Million | 49.88 Million | 32.8 Million | -51.97 Million | 21.01 Million | 134.99 Million |
| Investing Cash Flow | -25.52 Million | -15.19 Million | -16.46 Million | -284.13 Million | -349.67 Million | -39.47 Million |
| Investments in PPE | -25.57 Million | -21.05 Million | -16.5 Million | -18.24 Million | -80.23 Million | -30.31 Million |
| Acquisitions | 55.6 Thousand | 29.24 Thousand | 39.35 Thousand | -8.26 Million | -7.91 Million | 15.69 Thousand |
| Investment purchases | - | - | - | -267.1 Million | -267.1 Million | - |
| Sales/Maturities of investments | - | 5.83 Million | - | -271.56 Thousand | 5 Million | - |
| Other Investing Activities | 55.6 Thousand | 29.23 Thousand | 39.35 Thousand | 1.26 Million | -7.9 Million | -9.17 Million |
| Financing Cash Flow | -33.29 Million | -42.92 Million | -36.86 Million | 104.83 Million | 430.28 Million | 262.95 Million |
| Debt repayment | -12.45 Million | -27.39 Million | -31.09 Million | -77.82 Million | -266.04 Million | -183.97 Million |
| Dividends payments | -35.61 Million | -62.62 Million | -37.69 Million | -56.17 Million | -56.17 Million | -5.46 Million |
| Common Stock Repurchased | - | -29.05 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -10.13 Million | -59.42 Million | -67.95 Million | 29.06 Million | 253.82 Million | 456.14 Million |
| Accounts receivables | - | -13.88 Million | - | -4.74 Million | -4.74 Million | -16.43 Million |
| Accounts payables | - | - | - | - | 62.6 Million | - |
| Inventory | - | -20.91 Million | - | 62.37 Million | 62.37 Million | -42.13 Million |
| Other working capital | - | - | - | 1.63 Million | 1.63 Million | 819.81 Thousand |
| Cash at beginning of period | 887.38 Million | 895.58 Million | 974.15 Million | 963.57 Million | 400 Million | 626.95 Million |
| Cash at end of period | 912.03 Million | 900.91 Million | 895.58 Million | 875.9 Million | 875.9 Million | 963.57 Million |
| Capital Expenditure | -25.57 Million | -21.05 Million | -16.5 Million | -18.24 Million | -80.23 Million | -30.31 Million |
| Effect of forex changes on cash | -9.39 Million | 1.08 Million | 1.88 Million | 4.29 Million | 20.45 Million | -1.06 Million |
| Net cash flow / Change in cash | 24.65 Million | 5.33 Million | -78.56 Million | -87.66 Million | 475.89 Million | 336.61 Million |
| Free Cash Flow | 67.28 Million | 43.8 Million | 38.58 Million | 69.1 Million | 294.59 Million | 83.87 Million |
MAV
603053
TRBK
PSA-PG
SHECY
EJFI